| Financial Year |
March 31 2022 |
| Monetary Funds |
3,717,129,293.66 |
| Held-for-trading Financial Assets |
2,244,226,014.21 |
| Notes Receivable |
186,155,230.66 |
| Accounts Receivable |
4,765,400,040.37 |
| Advances to Suppliers |
558,374,460.01 |
| Other Receivables |
40,678,096.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,640,955,706.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
330,014,889.29 |
| Total Current Assets |
19,456,336,585.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,442,686,916.88 |
| Investment Properties |
-- |
| Fixed Assetes |
2,155,559,333.90 |
| Under-construction Projects |
775,402,301.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
577,927,511.88 |
| R&D expenses |
-- |
| Goodwill |
1,920,689,165.15 |
| Long-Term Deferred and Prepaid Expenses |
151,603,829.11 |
| Deferred Income Tax Assets |
651,567,097.25 |
| Other Non-Current Assets |
496,384,774.48 |
| Sub-Total of Non-Current Assets |
9,197,000,495.52 |
| Total Assets |
28,653,337,080.54 |
| Short-Term Loans |
888,951,210.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,496,786,575.12 |
| Accounts Payable |
3,244,654,505.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
937,428,522.31 |
| Taxes Payable |
139,716,977.76 |
| Interest Payable |
-- |
| Dividend Payable |
55,637,330.81 |
| Other payables |
408,742,208.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,280,148,104.86 |
| Other Current Liabilities |
227,714,751.54 |
| Sub-Total of Current Liabilities |
11,190,161,849.59 |
| Long-term Loans |
76,561,706.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
181,934,198.77 |
| Deferred Income Tax Liabilities |
66,788,033.07 |
| Other Non-Current Liabilities |
33,397,118.79 |
| Sub-Total of Non-Current Liabilities |
483,397,204.28 |
| Total Liabilities |
11,673,559,053.87 |
| Paid-In Capital(Or Share Stock) |
2,635,159,926.00 |
| Capital Surplus |
4,245,896,818.43 |
| Surplus Reserve |
868,669,296.64 |
| LESS:Treasury Stock |
150,000,916.81 |
| Undistributed Profits |
8,892,893,247.00 |
| Minority Stockholder's Interest |
494,879,548.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,484,898,477.73 |
| Owner's Equity（Stockholder's Equity） |
16,979,778,026.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,653,337,080.54 |
